The Canadian Competition Bureau issues draft IP enforcement guidelines that will have practical implications for the pharmaceutical industry

Canada’s Updated Draft Intellectual Property Enforcement Guidelines and the Pharmaceutical Industry* I. INTRODUCTION In June 2015, Canada’s Competition Bureau released its updated draft of the Intellectual Property Enforcement Guidelines (“Draft IPEGs”) for public review and consultation. The Draft IPEGs are intended to reflect the 2009 amendments to the Competition Act (the “Act”), including the changes to the criminal conspiracy provisions and the introduction of a new civil competitor collaboration provision. The Draft IPEGs are also designed to ensure consistency with other Bureau guidelines that have been released since the 2009 amendments (such as the Bureau’s Competitor Collaboration Guidelines). The other principal objective of the Draft IPEGs is to set out the Bureau’s initial

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Davies Ward Phillips & Vineberg (Toronto)
  • Davies Ward Phillips & Vineberg (Toronto)

Quotation

Anita Banicevic, Mark C. Katz, The Canadian Competition Bureau issues draft IP enforcement guidelines that will have practical implications for the pharmaceutical industry, 9 June 2015, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 76176

Visites 69

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues